Seonglae ChoHIV-prevention
Gilead’s twice-yearly injection
Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.
https://www.cnbc.com/2024/06/20/gilead-prep-lenacapavir-succeeds-in-phase-3-trial.html
A twice-yearly injection offers 100% protection against HIV, study suggests
Researchers reported no infections in the young women and girls who got the shots in a study of about 5,000 in South Africa and Uganda.
https://www.nbcnews.com/health/health-news/hiv-injection-twice-yearly-offers-protection-rcna163406
An injectable HIV-prevention drug is highly effective — but wildly expensive
Thrilled that lenacapavir, which is injected twice yearly, was highly effective in both gay men and women in clinical trials, HIV advocates worry it will prove too expensive for insurers.
https://www.nbcnews.com/nbc-out/out-health-and-wellness/injectable-hiv-prevention-drug-lencapavir-rcna170778
Yeztugo
FDA approves powerful HIV drug that nearly eliminated spread in clinical trials
The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.
https://www.nbcnews.com/health/health-news/fda-hiv-prevention-drug-prep-lenacapavir-rcna208387
